COVIRNA is a patient-centred Innovation Action aiming to generate a diagnostic tool to identify COVID-19 patients at risk of developing fatal cardiovascular complications.
A joined-up EU wide approach to protecting our population.
Keep in touch
Sign up to our mailing list to receive occasional emails as we publish key project materials and commission new strands of work.
Identifying those at most risk from COVID-19
The overall goal of the COVIRNA project is to generate a diagnostic test based on cardiovascular RNA biomarkers highly predictive of the clinical outcomes of COVID-19 patients and to enable its rapid market uptake with the aim to improve individualised surveillance, care and follow-up of these patients in the context of the current pandemic.Find out more about the project
How we will do it
Our work packages are evolving, but include consideration and development of:
Existing & past
The LIH, through the Cardiovascular Research Unit of the Department of Population Health (DoPH), led by Dr Yvan Devaux, will be the Coordinator of “COVIRNA”. The consortium of organisations delivering COVIRNA includes:
News & Events
The COVIRNA project concludes with its final conference
Even though the acute phase of the pandemic is over, COVID-19 is not. The disease causes long term sequelae in patients, which have been grouped under the term long-COVID. It is therefore important to continue working on finding solutions for these complications, in order to offer personalised, p…
Our webinar highlights the need of reliable prognostic tests to personalise long COVID patients’ pathways
On 2 March 2023, COVIRNA hosted the webinar ‘Patient-centred approaches to long COVID’. Moderated by Mr George Valiotis, Executive Director at EHMA, this webinar focused on overcoming the challenges posed by long COVID. Dr Tomas Zapata, Programme Manager in the Division of Country Health Policies…
Join our final conference ‘Improving personalised care and patient outcomes through molecular diagnostics and therapy’
At the dawn of the pandemic, the European Commission earmarked a large envelop to develop rapid health-related approaches to respond to the COVID-19 pandemic and to deliver quick results for society for a higher level of preparedness of health systems including medical supplies, equipment, techno…